8-K

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported):July 28, 2022

CLEARSIGN TECHNOLOGIES CORPORATION

(Exact name of registrant as specified in Charter)

12870 Interurban Avenue South

Seattle**,Washington 98168**

(Address of Principal Executive Offices)

206-673-4848

(Issuer Telephone number)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2 below).

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

On July 28, 2022, Bruce A. Pate notified the Board of Directors (the “Board”) of ClearSign Technologies Corporation (the “Company”) that he will resign effective August 1, 2022 (the “Effective Date”). At the time of his resignation, Mr. Pate was a member of the Board’s Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee (the “Nominating Committee”). His decision to resign is not the result of any disagreement with management or the Board related to the Company’s operations, policies, or practices.

In connection with Mr. Pate’s resignation, the Board, upon recommendation of the Nominating Committee, appointed Gary DiElsi as a new director to fill the vacancy created by Mr. Pate’s resignation.

As an independent director, Mr. DiElsi has also been appointed to serve as a member of the Board’s Audit Committee and Compensation Committee.

Since April 2018, Mr. DiElsi has served as Managing Member and Founder of Mountain Pass Energy Investing LLC, where he acts as an consultant and investment advisor. From July 2012 until April 2017, Mr. DiElsi served as Managing Director at Alinda Capital Partners, an infrastructure investment firm. At Alinda Capital Partners, Mr. DiElsi was on the Investment Committee for energy investments and was responsible for evaluation of opportunities and management of energy infrastructure investments, including due diligence, macro-strategy, structuring, monitoring, performance improvements. Further, while at Alinda Capital Partners, Mr. DiElsi oversaw a portfolio of a world-scale marine oil terminal, natural gas gathering, processing, pipelines, storage and liquid terminals and was a General Partner Martin Midstream (a public master limited partnership). Previously, Mr. DiElsi held numerous positions in other industries, such as private equity, major global enterprises, smaller industrial companies and startup ventures, including 6 years each at First Reserve Corporation and Oxbow Group, 12 years with Chevron Corporation, 2 years with Linde AG and 2 years with UOP. Mr. DiElsi also serves as a member of the Board of Directors of TopSail Energy, a private company. Mr. DiElsi has a Bachelor of Science (B.S.) in Mechanical Engineering (thermal sciences), Summa Cum Laude, as well as Master of Engineering in Mechanical Engineering, both from Rensselaer Polytechnic Institute.

In connection with his appointment, Mr. DiElsi received an offer letter from the Company, dated as of July 28, 2022 and effective as of the Effective Date (the “Offer Letter”), setting forth the terms of Mr. DiElsi’s services as a director and his compensation arrangement, which he accepted. Pursuant to the Offer Letter and in accordance with the Company’s director compensation policies, Mr. DiElsi will be granted restricted stock units under the Company’s 2021 Equity Incentive Plan valued at $15,000 on the grant date, which will be the first day of every quarter that Mr. DiElsi serves on the Board (the “Grant Date”). The Board may also award additional restricted stock units to Mr. DiElsi on the Grant Date, with values ranging from $750 to $1,875 per quarter, for serving on Board committees, as applicable.

The foregoing description of the Offer Letter does not purport to be a complete description of the rights and obligations of the parties thereunder and is qualified in its entirety by reference to the Offer Letter, which is included as Exhibit 10.1 to this current report on Form 8-K.

There are no arrangements or understandings between Mr. DiElsi and any other person pursuant to which he was selected as a director. There are no family relationships between Mr. DiElsi and any of our officers and directors and there is no transaction between the Company and Mr. DiElsi that is required to be disclosed pursuant to Item 404(a) of Regulation S-K.

d)  Exhibits.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Exhibit 10.1

July 28, 2022

Gary J. DiElsi

18 Pierrepont Drive

Ridgefield, CT 06877

Dear Gary:

On behalf of ClearSign Technologies Corporation (the “Company,” “ClearSign,” “we,” “our” or “us”) and our Board of Directors (“Board”), I am pleased to offer you a position as a member of our Board. We look forward to working with you on the Board. Should you choose to accept this position as a member of the Board, including potential service on committees of the Board, this letter shall constitute an agreement (the “Agreement”) between you and the Company and contains all the terms and conditions relating to the services to be provided.

1.	Term. This Agreement shall be through the date of the next annual shareholders’<br>meeting expected in early June 2023 and commencing on July 28, 2022. Your term as director shall continue until your successor is duly<br>elected and qualified. The position shall be up for re-election each year at the annual shareholders' meeting and upon re-election, the<br>terms and provisions of this Agreement shall remain in full force and effect. You also agree to resign from the Board of Directors if<br>requested by a majority of the then-sitting members of the Board. This Agreement shall be in effect as long as you are a director on the<br>Board.
2.	Services. You shall render services in the area of managing or directing<br>the Company's property, affairs and business (hereinafter, your “Duties”). You shall consult with other members of<br>the Board at meetings held quarterly, or more regularly if required, in locations determined by the Chairman of the Board of the Company.<br>You agree that your relationship with the Company will be that of a director and not that of an employee. Nothing in this Agreement is<br>intended to replace, supersede or diminish any of your duties to the Company as a director under state law. You also agree to comply with<br>all federal and state securities laws as well as Company policies, as applicable.
---	---
3.	Services for Others. You are free to represent or perform services for other<br>persons during the term of this Agreement. However, you agree that you do not presently perform and do not intend to perform, during the<br>term of this Agreement, similar Duties, consulting or other services for companies whose businesses are or would be, in any way, in conflict<br>or competitive with the Company (except for companies previously disclosed by you to the Company in writing). Should you propose to perform<br>similar Duties, consulting or other services for any such company, you agree to notify the Company in writing in advance (specifying the<br>name of the organization for whom you propose to perform such services) and to provide sufficient information to the Company to allow<br>it to determine if the performance of such services would conflict with areas of interest to the Company.
---	---
4.	Compensation to Independent Directors. In consideration for your service<br>as a member of the Board of Directors of the Company, you will receive an award of restricted stock units valued at $15,000 on the grant<br>date, which will be the first day of every quarter that you serve on the Board. The Company may also award additional restricted stock<br>units to you on the first day of each quarter, with values ranging from $750 to $1,875 per quarter, should you join any board committees.<br>These restricted stock units will vest upon death, departure from the board or a “change of control,” as such term is defined<br>in the applicable Agreement as determined by the Compensation Committee and in accordance with the terms and conditions of the Company's<br>2021 Equity Incentive Plan. The Company will also reimburse you for reasonable expenses incurred in connection with the performance of<br>your Duties as a director in accordance with the Company’s expense policy then in effect. Should you join the Board or any committee<br>of the Board after the first day of any quarter, you will receive an award of restricted stock units that is pro-rated for the number<br>of days remaining in such quarter.
---	---
5.	D&O Insurance Policy. You will be entitled to coverage under our Directors<br>and Officers liability insurance as then in effect.
---	---
6.	Assignment. Because of the personal nature of the services to be rendered<br>by you, this Agreement may not be assigned by you. The Company shall be free to transfer any of its rights under this Agreement to any<br>affiliate or third party.
---	---
7.	Confidential Information; Non-Disclosure. In consideration of your access<br>to the premises of the Company and your access to certain Confidential Information of the Company, in connection with your business relationship<br>with the Company, you hereby represent and agree as follows:
---	---
a.	Definition. For purposes of this Agreement the term “Confidential<br>Information” means:
---	---
i.	Any information which the Company possesses that has been created, discovered or<br>developed by or for the Company, and which has or could have commercial value or utility in the business in which the Company is engaged;<br>or
---	---
ii.	Any information that is related to the business of the Company and is generally<br>not known by non-Company personnel.
---	---
iii.	By way of illustration, but not limitation, Confidential Information includes trade<br>secrets and any information concerning products, processes, formulas, designs, inventions (whether or not patentable or registrable under<br>copyright or similar laws, and whether or not reduced to practice), discoveries, concepts, ideas, improvements, techniques, methods, research,<br>development and test results, specifications, data, know-how, software, formats, marketing plans, and analyses, business plans and analyses,<br>strategies, forecasts, customer and supplier identities, characteristics and Agreements.
---	---
b.	Exclusions. Notwithstanding the foregoing, the term Confidential Information<br>shall not include:
---	---
i.	Any information which becomes generally available to the public other than as a<br>result of a breach of the confidentiality portions of this Agreement, or any other Agreement requiring confidentiality between the Company<br>and you;
---	---
ii.	Information received from a third party in rightful possession of such information<br>who is not restricted from disclosing such information; and
---	---
iii.	Information known by you prior to receipt of such information from the Company,<br>which prior knowledge can be documented.
---	---
8.	Documents.<br>You agree that, without the express written consent of the Company, you will not remove from the Company's premises, any notes, formulas,<br>programs, data, records, machines or any other documents or items which in any manner contain or constitute Confidential Information,<br>nor will you make reproductions or copies of same. In the event you receive any such documents or items by personal delivery from any<br>duly designated or authorized personnel of the Company, you shall be deemed to have received the express written consent of the Company.<br>In the event that you receive any such documents or items, other than through personal delivery as described in the preceding sentence,<br>you agree to inform the Company promptly of your possession of such documents or items. You agree to promptly return any such documents<br>or items, along with any reproductions or copies to the Company upon the Company's demand or upon termination of this Agreement or your<br>departure from the Board.
---	---
9.	Non-Disparagement. **** You agree to forbear from making, causing<br>to be made, publishing, ratifying or endorsing any and all disparaging remarks, derogatory statements or comments to any third party with<br>respect to the Company and its affiliates, including, without limitation, the Company’s parent, subsidiaries, officers, directors<br>and employees (collectively, “Company Parties”). Further, you hereby agree to forbear from making any public or non-confidential<br>statement with respect to any of the Company Parties. The duties and obligations of this paragraph 9 shall continue following the termination<br>of this Agreement.
---	---
10.	Non-Solicitation. You agree and covenant not to directly or indirectly solicit,<br>hire, or recruit for your own benefit or the benefit of any other person, or so attempt to solicit, hire, or recruit, any employee of<br>the Company, or induce any other employee of the Company to terminate their employment for two (2) years immediately following your cessation<br>of services to the Company, regardless of the reason. This non-solicitation paragraph explicitly covers all forms of oral, written, or<br>electronic communication, including, but not limited to, communications by email, regular mail, express mail, telephone, fax, instant<br>message, and social media, including, but not limited to, Facebook, LinkedIn, Instagram, and Twitter, and any other social media platform,<br>whether or not in existence at the time of entering into this Agreement.
---	---
11.	No Disclosure. You agree that you will hold in trust and confidence all<br>Confidential Information and will not disclose to others, directly or indirectly, any Confidential Information or anything relating to<br>such information without the prior written consent of the Company, except as maybe necessary in the course of his business relationship<br>with the Company. You further agree that you will not use any Confidential Information without the prior written consent of the Company,<br>except as may be necessary in the course of your business relationship with the Company, and that the provisions of this paragraph 11<br>shall survive termination of this Agreement.
---	---
12.	Termination. This Agreement shall terminate in the event of your resignation<br>or termination as a director, or your refusal to stand for re-election or decision not to be nominated or if you are not re-elected for<br>additional terms as a director, effective on the date of your departure from the Board.
---	---
13.	Entire Agreement; Amendment; Waiver. Other than any requirements and duties<br>under applicable law, this Agreement expresses the entire understanding with respect to the subject matter hereof and supersedes and terminates<br>any prior oral or written Agreements with respect to the subject matter hereof. Any term of this Agreement may be amended and observance<br>of any term of this Agreement may be waived only with the written consent of the parties hereto. Waiver of any term or condition of this<br>Agreement by any party shall not be construed as a waiver of any subsequent breach or failure of the same term or condition or waiver<br>of any other term or condition of this Agreement. The failure of any party at any time to require performance by any other party of any<br>provision of this Agreement shall not affect the right of any such party to require future performance of such provision or any other<br>provision of Agreement.
---	---
14.	Enforcement.
---	---
a.	Applicable Law. This Agreement and the rights and remedies of each party<br>arising out of or relating to this Agreement (including, without limitation, equitable remedies) shall be solely governed by, interpreted<br>under, and construed and enforced in accordance with the laws (without regard to the conflicts of law principles thereof) of the State<br>of Washington, as if this Agreement were made, and as if its obligations are to be performed, wholly within the State of Oklahoma.
---	---
b.	Consent to Jurisdiction and Venue. Any action or proceeding arising out<br>of or relating to this Agreement shall be filed in and heard and litigated solely before the state or federal courts of Oklahoma within<br>Tulsa County.
---	---
c.	Attorneys’ Fees. If court proceedings are required to enforce any<br>provision of this Agreement, the substantially prevailing or successful party shall be entitled to an award of the reasonable and necessary<br>expenses of litigation, including reasonable attorneys’ fees.
---	---

I appreciate your willingness to serve on ClearSign’s Board and look forward to working with you to serve the Company together. Please indicate your acceptance by signing and returning the enclosed copy of this letter.